International Bookstore: Intellectual Property | Biotech, Pharma & Nutrition
World Protection and Exploitation
Duncan Bucknell
Oxford University Press
2011. ca. 2287 S.
EUR 365,89
This book highlights the special issues arising in obtaining, commercialising, enforcing or attacking intellectual property rights (including protection of regulatory data) in the pharmaceutical, biotechnology and chemical industries across the world's key jurisdictions. It is unique in presenting topic matter horizontally by subject to facilitate comparison between country practices.
The jurisdictions covered are the United States, Europe (UK, Germany, Netherlands, France and Italy), Japan, Canada, Australia, India and China.
|
 Who Decides?
Caroline Mullen
Cambridge University Press
248 Seiten
EUR 69,20
This volume maps the areas of ethical concern in the debate regarding the governance of genetic information, and suggests alternative ethical frameworks and models of regulation in order to inform its restructuring. Genetic governance is at the heart of medical and scientific developments, and is connected to global exploitation, issues of commodification, commercialisation and ownership, the concepts of property and intellectual property and concerns about individual and communal identity. Thus the decisions that are made in the next few years about appropriate models of genetic governance will have knock-on effects for other areas of governance....
|
 Mark Anderson
Oxford University Press
EUR 672,74
This looseleaf provides precedent agreements and legal commentary in relation to the main types of commercial transaction encountered in the life-cycle of a product in the biotechnology and pharmaceutical industries. Each agreement is accompanied by detailed commentary on legal, commercial and practice issues. In addition the commentary highlights important differences between English law and other key EU jurisdictions comprising Germany, France, the Netherlands, Spain and Sweden with specific commentary being provided by specialist lawyers within these countries.
|
 Barry Atwood; Katherine Thompson; Chris Willett
Bloomsbury
450 Seiten
EUR 139,85
Embracing relevant developments, including: the latest CAP rules on marketing standards; protected names and organic products, this new edition also considers significant changes of wider concern. Such changes include: the impact of Human Rights legislation on strict liability offences; the effect of the Government of Wales Act 2006 and the establishment of the Department for Environment, Food and Rural Affairs.
|
|
 Philip Grubb
Oxford University Press
4th ed., 544 S.
EUR 134,55
This is the eagerly awaited fourth edition of Philip Grubb's acclaimed book on patent law and practice. It guides the reader through the legal and procedural complexities of the British, European, Japanese and US patent systems, and explains in detail the role of patent practitioners (both in-house and in private practice) in maximising the commercial potential of their client's or company's innovative products.
|
 EIPR Practice Guide
Steinberg, Jane / Gill, Kelly / Tam, Roger
Sweet & Maxwell, UK
EUR 126,80
This book is a practical guide to the major IP issues pharmaceutical companies encounter when bringing new products to the market as well as issues they need to deal with post-commercialization.
Giving you an overview of the regulatory environment from a national and international perspective this title provides you with an understanding of this area of law and all it involves. It explains how patents and other IP protection can be used for new and innovative products enabling you to see what can be done to protect your new products.
|
|
 Elsenheimerstr. 41-43, 80687 München
www.schweitzer-online.de
Tel. 089-55134-0 - Fax 089-55134-101
Bettina Kube - T. 089-55134-248
b.kube@schweitzer-online.de
|
